홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sulfuric Acid → Ibuprofen, (+-)-

HRID 1449227
인쇄

반응식

HRID 1449227 반응식
[O-:1][C:2]([CH:4]([C:6]1[CH:15]=[CH:14][C:9]([CH2:10][CH:11]([CH3:13])[CH3:12])=[CH:8][CH:7]=1)[CH3:5])=[O:3].[Na+].S(=O)(=O)(O)O.[Cl-].[Na+]>>[OH:3][C:2]([CH:4]([C:6]1[CH:7]=[CH:8][C:9]([CH2:10][CH:11]([CH3:12])[CH3:13])=[CH:14][CH:15]=1)[CH3:5])=[O:1]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 1118Sulfuric AcidHCID 5234Sodium ChlorideHCID 5338317Ibuprofen, Sodium Salt

생성물 1

HCID 3672Ibuprofen, (+-)-수율 93.2%

실험 절차

The aqueous basic fraction containing sodium ibuprofen salt was acidified with 6N sulfuric acid, sodium chloride was added, and then extracted twice with Skellysolve B to take up the ibuprofen acid product therein. The Skellysolve B phase was dried over sodium sulfate and evaporated to leave as residue 867.7 mg. (93.2 percent yield) of ibuprofen which was 99.9 percent pure by gas liquid chromatographic (GLC) analysis.

후처리

  1. additionwas added
  2. extractionextracted twice with Skellysolve B
  3. dry with materialThe Skellysolve B phase was dried over sodium sulfate
  4. customevaporated
  5. customto leave as residue 867.7 mg

출처 및 근거

ORD 기록
ord-9fb0f63a25da4ea98b6394c83ae0b917
출처 데이터셋
uspto-grants-1980_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04189596

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트